Clinical Trial in Females With Female Pattern Hair Loss
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This is a year-long clinical trial to evaluate the effectiveness and safety in women with
Female Pattern Hair Loss (FPHL), comparing a new 5% minoxidil topical foam (MTF) formulation
applied once a day versus the 2% minoxidil topical solution (MTS) applied twice a day.
This clinical trial uses an objective measurement called Target Area Hair Count (TAHC) to
evaluate if there is a change in the number of hairs in the area being examined after using
the product for 24 weeks (and also after using the product for 12 Weeks and for 52 weeks).
This trial will determine if the benefit of using either study product outweighs the risks.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.